(Q80496709)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

An evaluation of patients' preferences for osteoporosis medications and their attributes: the PREFER-International study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

author name string

Jesús Walliser Duarte

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Susan C Bolge

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Shuvayu S Sen

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

publication date

1 March 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

published in

Clinical Therapeutics

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

488-503

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial

1 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis. Vertebral Efficacy with Risedronate Therapy (VERT) Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial. Vertebral Efficacy With Risedronate Therapy (VERT) Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Compliance with drug therapies for the treatment and prevention of osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Compliance with osteoporosis medications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

The impact of compliance with osteoporosis therapy on fracture rates in actual practice.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Assessment of compliance with osteoporosis treatment and its consequences in a managed care population

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Compliance with pharmacologic therapy for osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Persistent bisphosphonate use and the risk of osteoporotic fractures in clinical practice: a database analysis study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Engaging patients in medical decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patient Self-management of Chronic Disease in Primary Care

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

How do patients' treatment preferences compare with those of clinicians?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Uncertain future of trials in osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

An evaluation of patient preferences for osteoporosis medication attributes: results from the PREFER-US study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Migraine therapy: development and testing of a patient preference questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Nonadherence and osteoporosis treatment preferences of older women: a qualitative study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Validation of a general measure of treatment satisfaction, the Treatment Satisfaction Questionnaire for Medication (TSQM), using a national panel study of chronic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

A new measure of patient satisfaction with ocular hypotensive medications: the Treatment Satisfaction Survey for Intraocular Pressure (TSS-IOP)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Validation of the HIV treatment satisfaction questionnaire (HIVTSQ).

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Subcutaneous injection survey: psychometric evaluation of a treatment satisfaction instrument associated with a novel HIV medication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Development of the satisfaction with inhaled asthma treatment questionnaire

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Development and validation of a disease‐specific treatment satisfaction questionnaire for gastro‐oesophageal reflux disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patient preference and willingness-to-pay for Humalog Mix25 relative to Humulin 30/70: a multicountry application of a discrete choice experiment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Quality of life, treatment satisfaction, and treatment preference associated with use of a pen device delivering a premixed 70/30 insulin aspart suspension (aspart protamine suspension/soluble aspart) versus alternative treatment strategies

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Reasons underpinning patients' preferences for various angina treatments

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Treatment options in knee osteoarthritis: the patient's perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

The effect of age, race and gender on preference scores for hypothetical health states.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

A clinical trial to evaluate the measurement properties of 2 direct preference instruments administered with and without hypothetical marker states.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Japanese doctors' preferred treatment choices for their hypothetical non-small cell lung cancer: how they would wish to be treated. National Chest Hospital Study Group for Lung Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Health outcomes variables important to patients in the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patients with osteoporosis prefer once weekly to once daily dosing with alendronate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, crossover study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Compliance with treatment regimens in chronic asymptomatic diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Measuring patients' preferences for treatment and perceptions of risk

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Construct Validation of the Health Belief Model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Social Learning Theory and the Health Belief Model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patient preference and adherence: comparative US studies between two bisphosphonates, weekly risedronate and monthly ibandronate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Representation of the elderly, women, and minorities in heart failure clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Participation in cancer clinical trials: race-, sex-, and age-based disparities

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

The importance of patient preferences in treatment decisions--challenges for doctors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Preferences for medical collaboration: patient-physician congruence and patient outcomes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Variability in patient preferences for participating in medical decision making: implication for the use of decision support tools

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Informed decision making in outpatient practice: time to get back to basics.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Involving patients in medical decisions: how can physicians do better?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Patients' preferences for participation in clinical decision making: a review of published surveys

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

What role do patients wish to play in treatment decision making?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Incorporating patients' preferences into medical decisions

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Promoting informed choice: transforming health care to dispense knowledge for decision making

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Mortality, morbidity, and assessment of fracture risk in male osteoporosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

Cost effectiveness of alendronate for the treatment of male osteoporosis in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2807%2980087-7

7 January 2021

10.1016/S0149-2918(07)80087-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17577470%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference